Customized Adherence Enhancement

BEHAVIORAL2 trials

Sponsors

University Hospitals Cleveland Medical Center, Case Western Reserve University

Conditions

Medication NonadherencePatient NoncomplianceSchizo Affective DisorderSchizophrenia

Phase 3

Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)

CompletedNCT04327843

Case Western Reserve UniversityMedication Nonadherence, Schizo Affective Disorder, Schizophrenia

Start: 2019-11-05End: 2020-07-30Updated: 2021-10-12

Unknown Phase

Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic

CompletedNCT01152697

University Hospitals Cleveland Medical CenterPatient Noncompliance

Start: 2010-06-30End: 2012-08-31Updated: 2014-12-30

Related Papers

An interventional pilot of customized adherence enhancement combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania.

2022-01-272 citations

Prospective Trial of Customized Adherence Enhancement Plus Long-Acting Injectable Antipsychotic Medication in Homeless or Recently Homeless Individuals With Schizophrenia or Schizoaffective Disorder

The Journal of Clinical Psychiatry2013-12-1539 citations